Evaluation of the Effect of SPN-812 (Viloxazine Extended-Release) on QTc Interval in Healthy Adults.
CONCLUSIONS: This study demonstrated that SPN-812 had no effect on cardiac repolarization or other ECG parameters in healthy adults, suggesting that it is not associated with a risk for cardiac arrhythmias or other electrocardiographic parameters.
PMID: 33049804 [PubMed - in process]
Source: Journal of Clinical Psychiatry - Category: Psychiatry Tags: J Clin Psychiatry Source Type: research
More News: ADHD | Arrhythmia | Avelox | Cardiac Arrhythmia | Cardiology | Electrocardiogram | Heart | Hyperactivity | Moxifloxacin | Psychiatry | Statistics | Study